Discover why Hims & Hers Health is a top telehealth leader with impressive growth potential and a promising future for ...

Financial writer highlights undervalued Hims & Hers Health with impressive growth potential and innovative product launches, ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward ...

Citigroup has recently reduced Hims & Hers Health Inc (HIMS) stock to Sell rating, as announced on January 10, 2025, according to Finviz. Earlier, on January 7, 2025, BTIG Research had initiated the ...

Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $29.72, signifying a -0.3% move from its prior day's close.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc. (NYSE:HIMS), reported a significant transaction involving ...

Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.

Andrew Dudum, the CEO of Hims & Hers Health Inc. (NYSE:HIMS), recently sold shares worth approximately $815,029, according to ...

In recent trading, Hims & Hers Health Inc (HIMS) stock price has shown some volatility, fluctuating 9.60% over the last five trades and -10.88% over the past 30 trades. This represents a notable shift ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Atricure (ATRC – Research Report) and Hims ...